Avid Bioservices, Inc. announced the appointment of two senior directors of business development with responsibility for driving CDMO business growth within North America, Europe and Asia. Jason C. Brady, Ph.D. will serve as senior director of business development for the eastern region of North America, as well as Europe. Sylvia Hinds has been named senior director of business development for the western region of North America in addition to the Asia Pacific region. Dr. Brady is an accomplished sales professional with an extensive track record of successfully securing new manufacturing contracts with biopharmaceutical clients. He most recently served as senior director of sales and business development at Aji Bio-Pharma, a leading global provider of biopharmaceutical contract development and manufacturing services. In his new role with Avid, Dr. Brady will be responsible for driving the continued growth and expansion of the company’s CDMO business in the eastern portion of North America and Europe. Ms. Hinds possesses nearly 17 years of experience in key business development roles in the CDMO and contract research organization (CRO) industries, having established specialized expertise in biologics, gene and cell therapy, and sterile fill/finish services. In these roles, she has demonstrated the proven ability to consistently develop and penetrate new markets and exceed sales revenue targets. In her new role with Avid, Ms. Hinds will be charged with expanding the company’s CDMO business with both new and existing clients in the western portion of North America and the Asia Pacific region.